1. Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
    Rachel Toth et al, 2017, Antioxidants CrossRef
  2. null
    Julia Starkova et al, 2018 CrossRef
  3. null
    Peter H. Wiernik, 2018 CrossRef
  4. An integrated approach to elucidate signaling pathways of dioscin-induced apoptosis, energy metabolism and differentiation in acute myeloid leukemia
    She-Hung Chan et al, 2018, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  5. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway
    Yuan Zhang et al, 2018, J. Cell. Biochem. CrossRef
  6. The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone
    Jonathan D. Diedrich et al, 2018, Curr Osteoporos Rep CrossRef
  7. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species
    Yashar Mesbahi et al, 2018, European Journal of Pharmacology CrossRef
  8. Cancer metabolism in space and time: Beyond the Warburg effect.
    Pierre Danhier et al, 2017, Biochim Biophys Acta Bioenerg CrossRef
  9. The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
    Angela Ianniciello et al, 2018, Front. Cell Dev. Biol. CrossRef
  10. Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
    Li Chen et al, 2019, RSC Adv. CrossRef
  11. TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
    Li Chen et al, 2019, RSC Adv. CrossRef
  12. The Metabolic Profiles in Hematological Malignancies
    Tao Liu et al, 2019, Indian J Hematol Blood Transfus CrossRef
  13. Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
    Nicolas Chapuis et al, 2019, Front. Oncol. CrossRef
  14. Precision medicine for TP53-mutated acute myeloid leukemia
    Marte Karen Brattås et al, 2019, Expert Review of Precision Medicine and Drug Development CrossRef
  15. Metabolic Plasticity of Acute Myeloid Leukemia
    null Kreitz et al, 2019, Cells CrossRef
  16. Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
    Isabel Castro et al, 2019, Cells CrossRef
  17. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
    Dong Xu et al, 2017, J Exp Clin Cancer Res CrossRef
  18. Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.
    Yogesh Rai et al, 2019, Biosci Rep CrossRef
  19. Fructose-1,6-bisphosphatase-1 decrease may promote carcinogenesis and chemoresistance in cervical cancer
    Haoran Li et al, 2017 CrossRef
  20. Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC.
    Mengmeng Li et al, 2020, J Cell Mol Med CrossRef
  21. mTOR Regulation of Metabolism in Hematologic Malignancies
    Simone Mirabilii et al, 2020, Cells CrossRef
  22. null
    Ana Hipólito et al, 2020 CrossRef
  23. Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML
    Silvia Basilico et al, 2020, Nat Commun CrossRef
  24. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer
    Hang Yang et al, 2019, Oncotarget CrossRef
  25. The hypoxia signalling pathway in haematological malignancies
    Marta Irigoyen et al, 2017, Oncotarget CrossRef
  26. Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer
    Ziliang Wang et al, 2020, Cell Biol Toxicol CrossRef
  27. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
    Luyao Long et al, 2020, Drug Resistance Updates CrossRef
  28. Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity
    Ida Sofie Grønningsæter et al, 2020, Cells CrossRef
  29. 2‑Deoxy‑D‑glucose enhances the anti‑cancer effects of idarubicin on idarubicin‑resistant P388 leukemia cells
    Taisuke Matsuo et al, 2020, Oncol Lett CrossRef
  30. Integral analyses of survival‑related long non‑coding RNA MIR210HG and its prognostic role in colon cancer
    Zhaohui Ruan et al, 2019, Oncol Lett CrossRef
  31. Long Non-Coding RNA Taurine Upregulated Gene 1 Targets miR-185 to Regulate Cell Proliferation and Glycolysis in Acute Myeloid Leukemia Cells in vitro


    Weide Zhang et al, 2020, OTT CrossRef
  32. B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia
    Lindsay Wilde et al, 2020, WJCO CrossRef
  33. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
    Sven de Mey et al, 2020, IJMS CrossRef
  34. Preferential Activity of Petiveria alliacea Extract on Primary Myeloid Leukemic Blast
    Ricardo Ballesteros-Ramírez et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  35. Glycolysis-induced drug resistance in tumors—A response to danger signals?
    Fabrizio Marcucci et al, 2021, Neoplasia CrossRef
  36. Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia‐induced pulmonary hypertension
    Lina Wang et al, 2021, Br J Pharmacol CrossRef
  37. null
    Andrew J. Robinson et al, 2021 CrossRef
  38. Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
    Mehrdad Izadirad et al, 2021, Drug Discovery Today CrossRef
  39. Mitochondria: The metabolic switch of cellular oncogenic transformation
    Yan Qin Tan et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  40. Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients
    Carlos Henrique F. Peiró et al, 2021, Sci Rep CrossRef
  41. The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia
    Vilma Dembitz et al, 2021, Front. Oncol. CrossRef
  42. Chemotherapy-induced peripheral neuropathy is promoted by enhanced spinal insulin-like growth factor-1 levels via astrocyte-dependent mechanisms
    Yue Le et al, 2021, Brain Research Bulletin CrossRef
  43. Mitochondrial Effects on Seeds of Cancer Survival in Leukemia
    Hend E. El-Shaqanqery et al, 2021, Front. Oncol. CrossRef
  44. Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
    Marilena Ciciarello et al, 2021, Cancers CrossRef
  45. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
    Mojdeh Soltani et al, 2021, Front. Oncol. CrossRef
  46. Tumour Microenvironment Stress Promotes the Development of Drug Resistance
    Nicole A. Seebacher et al, 2021, Antioxidants CrossRef
  47. A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.
    Carla Ijurko et al, 2022, Am J Hematol CrossRef
  48. Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
    Yashar Mesbahi et al, 2022, Front. Oncol. CrossRef
  49. Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia
    Yi Xu et al, 2022, Biomark Res CrossRef
  50. H22954, a long non-coding RNA, inhibits glucose uptake in leukemia cells in a GLUT10-dependent manner
    Yujia Bai et al, 2022, Hematology CrossRef
  51. Shikonin impairs mitochondrial activity to selectively target leukemia cells
    Alessia Roma et al, 2022, Phytomedicine Plus CrossRef
  52. Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
    Fengli Zuo et al, 2022, Front. Oncol. CrossRef
  53. Exposure to cytarabine causes side effects on adult development and physiology and induces intestinal damage via apoptosis in Drosophila
    Shuzhen Han et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  54. Causal associations between site-specific cancer and diabetes risk: A two-sample Mendelian randomization study
    Rong Xu et al, 2023, Front. Endocrinol. CrossRef
  55. Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance
    Cindy Mayerli Arévalo et al, 2023, Front. Mol. Biosci. CrossRef
  56. Dissecting the Role of Autophagy-Related Proteins in Cancer Metabolism and Plasticity
    Liliana Torres-López et al, 2023, Cells CrossRef
  57. null
    Livia E. Lisi-Vega et al, 2023 CrossRef
  58. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1
    Changmei Hu et al, 2023, DARU J Pharm Sci CrossRef
  59. TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
    Mahnaz Rezaei et al, 2023, Front. Immunol. CrossRef
  60. Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors
    Abbas Ranjbar et al, 2023, Iran J Pharm Res CrossRef
  61. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
    Maryam Bakhtiyari et al, 2023, Cell Commun Signal CrossRef
  62. null
    Xiaoyuan Zeng et al, 2023 CrossRef
  63. Metabolic instruction of the graft-versus-leukemia immunity
    Ann-Cathrin Burk et al, 2024, Front. Immunol. CrossRef
  64. Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
    Jenna L. Carter et al, 2023, Biochemical Pharmacology CrossRef
  65. The down-regulation of GADD45B leads to a conversion of cellular oxidative phosphorylation to glycolysis and promotes the progression of bladder cancer
    Kai-yun Wang et al, 2024, Heliyon CrossRef
  66. Metabolic dependencies of acute myeloid leukemia stem cells
    Xiangguo Shi et al, 2024, Int J Hematol CrossRef
  67. Effect of HPV Oncoprotein on Carbohydrate and Lipid Metabolism in Tumor Cells
    Biqing Chen et al, 2024, CCDT CrossRef
  68. Potential Correlation between Gene Mutations and Metabolic Changes in Acute Myeloid Leukemia
    Aili Jiang et al, 2024, NPJ CrossRef
  69. Glycolysis and chemoresistance in acute myeloid leukemia
    Yan Yang et al, 2024, Heliyon CrossRef
  70. ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK/PI3K/AKT signaling
    Muxia Yan et al, 2024, International Immunopharmacology CrossRef
  71. Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview
    Isabella Spinello et al, 2024, IJMS CrossRef
  72. Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemia
    Hiroki Yamaguchi, 2024, Int J Hematol CrossRef
  73. GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance by mediating glucose metabolic symbiosis
    Xiaofei He et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  74. Glycolysis and immunosenescence: key players in the pathogenesis of acute myeloid leukemia and their therapeutic potential
    Tao Chang et al, 2024 CrossRef
  75. Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
    Elissa Tjahjono et al, 2025, Front. Oncol. CrossRef